Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Cell and Gene Therapy Contract Development and Manufacturing Organization Market Report is Segmented by Product (Cell Therapy and Gene Therapy), Source (Pre-Clinical, Clinical, and Commercial), Indication (Oncology, Cardiovascular Disease, Infectious Disease, Genetic Disorders, Neurological Disorders, and Other Indications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Cell And Gene Therapy Contract Development And Manufacturing Organization Industry Overview

The market for cell and gene therapy contract development and manufacturing organizations is moderately competitive, with the presence of both small and large players who are involved in strategic activities such as the expansion of services, partnerships, collaborations, as well as mergers, and acquisitions. Catalent, Inc., Lonza, Wuxi Biologics, and Recipharm Ab are among the notable key players in this market.

Cell And Gene Therapy Contract Development And Manufacturing Organization Market Leaders

  1. Catalent Inc

  2. Lonza Group

  3. Recipharm AB

  4. Charles River Laboratories International Inc

  5. Wuxi Advanced Therapies

  6. *Disclaimer: Major Players sorted in no particular order
Cell And Gene Therapy Contract Development And Manufacturing Organization Market Concentration

Cell And Gene Therapy Contract Development And Manufacturing Organization Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?